Pooled analysis reported no significant effect on complete AV block outcomes from treatment with GLP-1RA versus placebo [RR=0.75, 95% CI (0.49, 1.17), p =0.21]
Sudden loss of appetite suppression and delayed gastric emptying effects Central satiety signals diminish quickly Metabolic adaptations (reduced energy expenditure, increased hunger hormones like ghrelin) rebound sharply The underlying biology of obesity a chronic, relapsing disease reasserts itself Could gradual down-titration help
We view GLP-1 injections as a safe and effective treatment for type 2 diabetes and a valuable tool in managing blood sugar levels and weight
Xianchu L, Kang L, Beiwan D, Huan P, Ming L
Until approval is granted, only licensed GLP-1-based metabolic hormone therapies can be supplied following a pharmacist-led consultation.